The evolution of clinical trials shows that although much has changed, several things remain the same. When a patient expresses interest in a trial, they complete an informed consent process, and ...
New Approach to Clinical Trial Design Helps Medical Devices Better Meet Patient Needs and Priorities
ARLINGTON, Va.--(BUSINESS WIRE)--A Medical Device Innovation Consortium (MDIC) program today released a new framework that provides U.S. medical device companies a systematic approach for ...
A cancer diagnosis is a life-changing experience. Survival and remission are, of course, the highest priority for most, but they are only part of the equation when treating cancer. Quality of life ...
A recent article from Mayo Clinic President and CEO Gianrico Farrugia, M.D., offers a compelling glimpse of what that future ...
The aim of the EU Clinical Trials Regulation (CTR) is to harmonise the clinical trial regulation process across 27 countries and have an 80-day approval timeline, stated Dr. Martine Dehlinger-Kremer, ...
The drug development industry is in the midst of a clinical trial revolution. Patient-centricity is the primary driver — and we should all embrace it. To be truly patient-centric, we, as an industry, ...
Clinical trials, often one of the most expensive parts of bringing a drug to market, can last as long as a decade. The Covid-19 pandemic has proven clinical trials can be successfully completed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results